A comprehensive PGx portfolio designed to deliver the results you need

Pharmacogenomics (PGx) is an exciting and powerful emerging field that promises to improve health care outcomes. PGx helps provide meaningful data that can help prevent adverse drug reactions and lower medical costs. When you partner with us, you gain access to a wide range of PGx genotyping solutions and the vast expertise we’ve acquired from a decade of driving advancements in PGx.

PGx research is part of the ongoing effort to tailor results to the individual by taking into account their genome, lifestyle, and other attributes. Like blood typing research before it, PGx research aims to avoid mismatches between individual cases and their respective approaches.

The future of health care includes factoring genetic test results into decisions.

Not sure where to begin? We can help you identify your testing requirements and make it easy for you to pick the right technology based on whether you need genotyping, copy number variation (CNV), and/or human leukocyte antigen (HLA) analysis.

Have content questions? We have carefully curated fixed content or flexible custom options, which will also guide your technology selection. We’re also here to help establish your workflow so that whether you’re testing for one target or 4,000, your lab is set up for success from the beginning. Rest assured that we continue to invest in developing innovative technologies that draw from our global network of specialists to make PGx accessible and affordable.

*Application supported via separate workflow

Featured news, events, and blogs

1. An-Economic-Evaluation-of-Pharmacogenomic-Testing.pdf (pro-genex.com)
2. Maciel A, Cullers A, Lukowiak AA, Garces J (2018) Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings. Neuropsychiatric disease and treatment 14: 225–230. https://doi. org/10.2147/NDT.S145046